Are there radiomic features derived from preoperative MR examinations that can predict response to neoadjuvant chemotherapy in patients with conventional osteosarcoma of the extremity?

Title

Code

Radiomics OSA

Type

Osservazionale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366836 (segreteria)

alberto.bazzocchi@ior.it

Bazzocchi Alberto, MD, PhD

Diagnostic and Interventional Radiology

Operational unit that carry out the study

complex unit

Radiologia diagnostica ed interventistica

Director

Miceli Marco, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Radiomics OSA

Monday 20 January 2025, 15:38

PG0018579_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Are there radiomic features derived from preoperative MR examinations that can predict response to neoadjuvant chemotherapy in patients with conventional osteosarcoma of the extremity?

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Are there radiomic features derived from preoperative MR examinations that can predict response to neoadjuvant chemotherapy in patients with conventional osteosarcoma of the extremity?

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in